PoliticalGuinea-Bissau·21 Oct 2026
US-funded Hepatitis B vaccine trial in Guinea-Bissau cancelled
AI-summarized · Neutrality-checked
A US-funded hepatitis B vaccine trial in Guinea-Bissau has been cancelled after the government denied the necessary project approvals. Lead researcher Frederik Schaltz-Buchholzer announced the halt after the Bissau-Guinean government seized the study's vaccines from the Bandim Health Project offices. The $3.2 million project, funded by the CDC and private…
Loading full story…
Sources and context
The Guardian
NewspaperTrust ownedUnited KingdomStandards published
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.